The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index; none of the 124 sources its claims cite is checked for support yet.
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Open accessPublished version of a preprint
Abstract
The ability to derive retinal ganglion cells (RGCs) from human pluripotent stem cells (hPSCs) has led to numerous advances in the field of retinal research, with great potential for the use of hPSC-derived RGCs for studies of human retinal development, in vitro disease modeling, drug discovery, as well as their potential use for cell replacement therapeutics. Of all these possibilities, the use of hPSC-derived RGCs as a human-relevant platform for in vitro disease modeling has received the greatest attention, due to the translational relevance as well as the immediacy with which results may be obtained compared to more complex applications like cell replacement. While several studies to date have focused upon the use of hPSC-derived RGCs with genetic variants associated with glaucoma or other optic neuropathies, many of these have largely described cellular phenotypes with only limited advancement into exploring dysfunctional cellular pathways as a consequence of the disease-associated gene variants. Thus, to further advance this field of research, in the current study we leveraged an isogenic hPSC model with a glaucoma-associated mutation in the Optineurin (OPTN) protein, which plays a prominent role in autophagy. We identified an impairment of autophagic-lysosomal degradation and decreased mTORC1 signaling via activation of the stress sensor AMPK, along with subsequent neurodegeneration in OPTN(E50K) RGCs differentiated from hPSCs, and have further validated some of these findings in a mouse model of ocular hypertension. Pharmacological inhibition of mTORC1 in hPSC-derived RGCs recapitulated disease-related neurodegenerative phenotypes in otherwise healthy RGCs, while the mTOR-independent induction of autophagy reduced protein accumulation and restored neurite outgrowth in diseased OPTN(E50K) RGCs. Taken together, these results highlighted that autophagy disruption resulted in increased autophagic demand which was associated with downregulated signaling through mTORC1, contributing to the degeneration of RGCs.
Overview
CoChat Summary
TL;DR
In isogenic hPSC-derived RGCs, the glaucoma-associated OPTN(E50K) mutation impaired autophagic-lysosomal degradation, reduced mTORC1 signaling via AMPK activation, and produced selective neurodegenerative phenotypes. mTOR-independent autophagy induction with trehalose rescued neurite outgrowth and reduced protein accumulation, whereas mTORC1 inhibition reproduced degenerative phenotypes in healthy RGCs.
Key findings
- OPTN(E50K) RGCs had unchanged OPTN mRNA but 41.1 ± 5.2% lower OPTN protein and 28.1 ± 4.3% higher p62; proteomics identified 154 downregulated and 178 upregulated proteins, including altered autophagy- and ubiquitination-associated proteins.
- Autophagic-lysosomal degradation was impaired: LC3-OPTN colocalization was 10.7 ± 1.2% in wild-type vs 5.1 ± 0.6% in OPTN(E50K) RGCs; LC3-II, LAMP1, and LC3-II/I were increased (p = 0.016, p = 0.0018, p = 0.039), and LC3-RFP-GFP showed more autophagosomes in OPTN(E50K) RGCs (35.8 ± 2.5% vs 25.5 ± 2.8% wild-type, p = 0.0075).
- mTORC1 signaling was reduced: pS6Ser240/244 decreased (p = 0.0057), pAKTSer473 was unchanged (p = 0.854), and pAMPKThr172 increased (p = 0.0027); in the mouse ocular hypertension model, pS6 decreased (p = 0.011) and LC3-II, LAMP1, and LC3-II/I increased (p = 0.034, p = 0.0004, p = 0.042).
- OPTN(E50K) caused RGC-selective neurite deficits, while cortical neurons showed no significant differences; mTOR inhibitor KU0063794 caused dose-dependent neurite shortening in healthy RGCs, and trehalose reduced OPTN puncta, reduced LC3-II, sustained pS6, and protected neurites in OPTN(E50K) RGCs.
Methods
- Isogenic hPSC model: H7 hESC and patient iPSC lines with OPTN(E50K) or CRISPR-corrected controls, with or without a BRN3b-tdTomato-Thy1.2 reporter; retinal organoids were differentiated, RGCs purified by CD90.2/Thy1.2 MACS, and matured up to 4 weeks; hPSC-derived cortical neurons were used for comparison.
- Mouse glaucoma model: adult female C57BL/6 mice (2–3 months, 20.3–25.1 g) received unilateral magnetic microbead anterior chamber injection to elevate intraocular pressure, with sham controls; retinas were analyzed 2 weeks after.
- Main assays: qPCR, immunoblotting, immunostaining, LC3-RFP-GFP autophagosome maturation assay, neurite tracing/Sholl analysis, TMT LC-MS/MS proteomics, and glucose uptake; statistics used t-test or ANOVA with Tukey post hoc, p < 0.05.
Limitations
- Stated: mouse autophagy findings used whole retina rather than purified RGCs, which may explain the less robust disruption compared with human hPSC-RGCs; the lack of OPTN protein difference in ocular hypertensive vs control mouse retinas could be due to analysis of total retinal protein rather than RGC content.
- Stated: whether decreased LC3 recruitment by OPTN directly causes autophagy defects or is compensated by other autophagy receptors remains undetermined, and whether AMPK regulates autophagy directly or indirectly through mTORC1 suppression still needs determination; the study also did not compare RGCs with other projection neurons such as motor neurons.
- Evident from the text: hPSC-derived RGCs are described as a somewhat immature developmental stage, so findings may not fully capture adult human RGC biology; several experiments rely on technical replicates with small biological n (e.g., n = 3 biological replicates), which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 1 Not valid · 64 Not checked · 143 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While the level of OPTN mRNA was not significantly changed among wild-type and OPTN(E50K) RGCs”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“along with a 28.1 ± 4.3% increase in the autophagy receptor p62”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our results show that RGCs subjected to insulin deprivation exhibited reduced glucose uptake (Figure S10)”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Altered mTOR signaling and autophagy modulated RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Insulin deprivation also decreased the mTORC1 effector pS6Ser240/244 in OPTN(E50K) RGCs (Figure S9 L-N)”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Altered mTOR signaling and autophagy modulated RGC neurodegenerative phenotypes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found that the number of OPTN puncta were significantly decreased in OPTN-E50K RGCs compared to control RGCs following chloroquine treatment”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
135 more claims
Create a free account to see all 208 claims and to verify the 124 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 29
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > Inhibition of mTOR signaling results in neurodegenerative phenotypes in otherwise healthy hPSC-RGCs
“pAMPKThr172 **p = 0.0292”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > The glaucoma associated OPTN(E50K) mutation alters endogenous protein modification and leads to protein accumulation in hPSC-RGCs
“**p < 0.01, *p < 0.05”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Introduction
“identified a disruption in OPTN protein processing along with a decrease in autophagic flux in hPSC-RGCs”
§ Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction > Results > OPTN(E50K) hPSC-RGCs display autophagosome accumulation and impaired autophagic-lysosomal degradation
“increased LC3-II, LAMP1 and autophagic flux (LC3-II to LC3-I ratio) in OPTN(E50K) hPSC-RGCs”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897 · cited 1×
“…degradation, we inhibited autophago-some-lysosome fusion by treatment with chloroquine for 16 h prior to fixation, as previously described [42], where we found that the number of OPTN puncta were significantly decreased in OPTN-E50K RGCs compared to control RGCs following chloroquine…”
MethodNutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., et al. (2008) · Science · doi:10.1126/science.1161566 · Cited by 1,686
ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
Ganley, I. G., Lam, D. H., Wang, J., Ding, X., Chen, S., & Jiang, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900573200 · Cited by 1,447
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Emerging regulation and functions of autophagy
Boya, P., Reggiori, F., & Codogno, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2788 · Cited by 1,216
Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146
Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142
Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin
Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Héon, E., Krupin, T., Ritch, R., Kreutzer, D., et al. (2002) · Science · doi:10.1126/science.1066901 · Cited by 1,105
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934
Compromised autophagy and neurodegenerative diseases
Menzies, F. M., Fleming, A., & Rubinsztein, D. C. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3961 · Cited by 851 · cited 1×
“Disruption of the autophagic-lysosomal pathway has been implicated in multiple neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis, leading to a deficit in protein degradation [45–47].”
BackgroundWong, Y. C., & Holzbaur, E. L. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405752111 · Cited by 812
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Inoki, K., Kim, J., & Guan, K.-L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134537 · Cited by 791
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782
Lipton, J. O., & Sahin, M. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.034 · Cited by 736
An Autophagic Flux Probe that Releases an Internal Control
Kaizuka, T., Morishita, H., Hama, Y., Tsukamoto, S., Matsui, T., Toyota, Y., Kodama, A., Ishihara, T., Mizushima, T., & Mizushima, N. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.037 · Cited by 575
The Pharmacology of mTOR Inhibition
Guertin, D. A., & Sabatini, D. M. (2009) · Science Signaling · doi:10.1126/scisignal.267pe24 · Cited by 568
Duan, X., Qiao, M., Bei, F., Kim, I.-J., He, Z., & Sanes, J. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.017 · Cited by 523
Insulin Signaling and the Regulation of Glucose Transport
Chang, L., Chiang, S.-H., & Saltiel, A. R. (2004) · Molecular Medicine · doi:10.2119/2005-00029.saltiel · Cited by 520
Casadio, A., Martin, K. C., Giustetto, M., Zhu, H., Chen, M., Bartsch, D., Bailey, C. H., & Kandel, E. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81653-0 · Cited by 503
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497
Molecular Classification and Comparative Taxonomics of Foveal and Peripheral Cells in Primate Retina
Peng, Y.-R., Shekhar, K., Yan, W., Herrmann, D., Sappington, A., Bryman, G. S., van Zyl, T., Do, M. T. H., Regev, A., & Sanes, J. R. (2019) · Cell · doi:10.1016/j.cell.2019.01.004 · Cited by 476
Meyer, J. S., Howden, S. E., Wallace, K. A., Verhoeven, A. D., Wright, L. S., Capowski, E. E., Pinilla, I., Martin, J. M., Tian, S., Stewart, R., et al. (2011) · Stem Cells · doi:10.1002/stem.674 · Cited by 469
Self-citationRusmini, P., Cortese, K., Crippa, V., Cristofani, R., Cicardi, M. E., Ferrari, V., Vezzoli, G., Tedesco, B., Meroni, M., Messi, E., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1535292 · Cited by 436 · cited 1×
“To this end, we choose trehalose as a means to modulate autophagy through mTOR-independent means, as trehalose is thought to induce Transcription Factor EB (TFEB) nuclear translocation and activation of autophagy-associated proteins independent to mTOR [99, 100].”
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Barmada, S. J., Serio, A., Arjun, A., Bilican, B., Daub, A., Ando, D. M., Tsvetkov, A., Pleiss, M., Li, X., Peisach, D., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1563 · Cited by 431
Palmieri, M., Pal, R., Nelvagal, H. R., Lotfi, P., Stinnett, G. R., Seymour, M. L., Chaudhury, A., Bajaj, L., Bondar, V. V., Bremner, L., et al. (2017) · Nature Communications · doi:10.1038/ncomms14338 · Cited by 383
The primate fovea: Structure, function and development
Bringmann, A., Syrbe, S., Görner, K., Kacza, J., Francke, M., Wiedemann, P., & Reichenbach, A. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.006 · Cited by 352
Castillo, K., Nassif, M., Valenzuela, V., Rojas, F., Matus, S., Mercado, G., Court, F. A., van Zundert, B., & Hetz, C. (2013) · Autophagy · doi:10.4161/auto.25188 · Cited by 340
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
Compartment-Specific Regulation of Autophagy in Primary Neurons
Maday, S., & Holzbaur, E. L. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4401-15.2016 · Cited by 309 · cited 1×
“…to only minimally activate autophagy in primary hippocampal neurons, and tau phosphorylation and Aβ metabolism likely hyperactivate mTOR in Alzheimer’s disease and Down syndrome, indicating that disruption of autophagy in Alzheimer’s disease-related neurode-generations is mTOR-independent [90–92].”
BackgroundMammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288
Zhang, X., Chen, S., Song, L., Tang, Y., Shen, Y., Jia, L., & Le, W. (2014) · Autophagy · doi:10.4161/auto.27710 · Cited by 259
Connecting the Retina to the Brain
Erskine, L., & Herrera, E. (2014) · ASN Neuro · doi:10.1177/1759091414562107 · Cited by 199
Bowles, K. R., Silva, M. C., Whitney, K., Bertucci, T., Berlind, J. E., Lai, J. D., Garza, J. C., Boles, N. C., Mahali, S., Strang, K. H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.003 · Cited by 182
Autophagy and Neuronal Cell Death in Neurological Disorders
Nixon, R. A., & Yang, D.-S. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008839 · Cited by 181
Shen, W.-C., Li, H.-Y., Chen, G.-C., Chern, Y., & Tu, P.-H. (2015) · Autophagy · doi:10.4161/auto.36098 · Cited by 169
Sluch, V. M., Chamling, X., Liu, M. M., Berlinicke, C. A., Cheng, J., Mitchell, K. L., Welsbie, D. S., & Zack, D. J. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0059 · Cited by 157
Shoemaker, C. J., Huang, T. Q., Weir, N. R., Polyakov, N. J., Schultz, S. W., & Denic, V. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2007044 · Cited by 150
Minegishi, Y., Iejima, D., Kobayashi, H., Chi, Z.-L., Kawase, K., Yamamoto, T., Seki, T., Yuasa, S., Fukuda, K., & Iwata, T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt210 · Cited by 138
Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
Evans, C. S., & Holzbaur, E. L. (2020) · eLife · doi:10.7554/elife.50260 · Cited by 137 · cited 1×
“During the process of autophagy, OPTN is necessary to recruit the microtubule-associated protein light chain 3 (LC3) for the engulfment of protein aggregates and/ or damaged organelles by formation of the autophago-some [29, 43].”
BackgroundEmerging views of OPTN (optineurin) function in the autophagic process associated with disease
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., & Weng, Q. (2022) · Autophagy · doi:10.1080/15548627.2021.1908722 · Cited by 134
Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice
Du, J., Liang, Y., Xu, F., Sun, B., & Wang, Z. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12108 · Cited by 129
Li, F., Xie, X., Wang, Y., Liu, J., Cheng, X., Guo, Y., Gong, Y., Hu, S., & Pan, L. (2016) · Nature Communications · doi:10.1038/ncomms12708 · Cited by 126
Clinical Features and Course of Patients with Glaucoma with the E50K Mutation in the Optineurin Gene
Aung, T., Rezaie, T., Okada, K., Viswanathan, A. C., Child, A. H., Brice, G., Bhattacharya, S. S., Lehmann, O. J., Sarfarazi, M., & Hitchings, R. A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1133 · Cited by 125
Agostinone, J., Alarcon-Martinez, L., Gamlin, C., Yu, W.-Q., Wong, R. O. L., & Di Polo, A. (2018) · Brain · doi:10.1093/brain/awy142 · Cited by 124
Ohlemacher, S. K., Sridhar, A., Xiao, Y., Hochstetler, A. E., Sarfarazi, M., Cummins, T. R., & Meyer, J. S. (2016) · Stem Cells · doi:10.1002/stem.2356 · Cited by 123
Self-citationCellular and Molecular Biology of Optineurin
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00005-7 · Cited by 122
Autophagosome dynamics in neurodegeneration at a glance
Wong, Y. C., & Holzbaur, E. L. F. (2015) · Journal of Cell Science · doi:10.1242/jcs.161216 · Cited by 119
Optineurin in neurodegenerative diseases
Osawa, T., Mizuno, Y., Fujita, Y., Takatama, M., Nakazato, Y., & Okamoto, K. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01199.x · Cited by 116
Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin
Anborgh, P. H., Godin, C., Pampillo, M., Dhami, G. K., Dale, L. B., Cregan, S. P., Truant, R., & Ferguson, S. S. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504508200 · Cited by 115
De Marco, N., Buono, M., Troise, F., & Diez-Roux, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601467200 · Cited by 106
VanderWall, K. B., Huang, K.-C., Pan, Y., Lavekar, S. S., Fligor, C. M., Allsop, A. R., Lentsch, K. A., Dang, P., Zhang, C., Tseng, H. C., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.009 · Cited by 100
Self-citationLi, Y., Guo, Y., Wang, X., Yu, X., Duan, W., Hong, K., Wang, J., Han, H., & Li, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.061 · Cited by 97
Ohlemacher, S. K., Iglesias, C. L., Sridhar, A., Gamm, D. M., & Meyer, J. S. (2015) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01h08s32 · Cited by 94
Self-citationYang, Y., Wang, Q., Song, D., Zen, R., Zhang, L., Wang, Y., Yang, H., Zhang, D., Jia, J., Zhang, J., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01701-z · Cited by 93
Optineurin Insufficiency Impairs IRF3 but Not NF-κB Activation in Immune Cells
Munitic, I., Giardino Torchia, M. L., Meena, N. P., Zhu, G., Li, C. C., & Ashwell, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301696 · Cited by 87
Studies of Optineurin, a Glaucoma Gene
Park, B.-C., Shen, X., Samaraweera, M., & Yue, B. Y. J. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060400 · Cited by 86
Slowicka, K., Vereecke, L., Mc Guire, C., Sze, M., Maelfait, J., Kolpe, A., Saelens, X., Beyaert, R., & van Loo, G. (2016) · European Journal of Immunology · doi:10.1002/eji.201545863 · Cited by 86
White, K. E., Davies, V. J., Hogan, V. E., Piechota, M. J., Nichols, P. P., Turnbull, D. M., & Votruba, M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2913 · Cited by 85
TBK1 Gene Duplication and Normal-Tension Glaucoma
Ritch, R., Darbro, B., Menon, G., Khanna, C. L., Solivan-Timpe, F., Roos, B. R., Sarfarzi, M., Kawase, K., Yamamoto, T., Robin, A. L., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.104 · Cited by 83
Survey of retinal ganglion cell morphology in marmoset
Masri, R. A., Percival, K. A., Koizumi, A., Martin, P. R., & Grünert, U. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24157 · Cited by 82
Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders
Linda, K., Lewerissa, E. I., Verboven, A. H. A., Gabriele, M., Frega, M., Klein Gunnewiek, T. M., Devilee, L., Ulferts, E., Hommersom, M., Oudakker, A., et al. (2022) · Autophagy · doi:10.1080/15548627.2021.1936777 · Cited by 80
Harkin, J., Peña, K. H., Gomes, C., Hernandez, M., Lavekar, S. S., So, K., Lentsch, K., Feder, E. M., Morrow, S., Huang, K.-C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317285121 · Cited by 79
Self-citationAutophagic dysregulation in glaucomatous trabecular meshwork cells
Porter, K., Hirt, J., Stamer, W. D., & Liton, P. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.021 · Cited by 78
Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress
Singh, K., Matsuyama, S., Drazba, J. A., & Almasan, A. (2012) · Autophagy · doi:10.4161/auto.8.2.18600 · Cited by 78
Shim, M. S., Takihara, Y., Kim, K.-Y., Iwata, T., Yue, B. Y. J. T., Inatani, M., Weinreb, R. N., Perkins, G. A., & Ju, W.-K. (2016) · Scientific Reports · doi:10.1038/srep33830 · Cited by 72
Differential regulation of autophagy during metabolic stress in astrocytes and neurons
Kulkarni, A., Dong, A., Kulkarni, V. V., Chen, J., Laxton, O., Anand, A., & Maday, S. (2020) · Autophagy · doi:10.1080/15548627.2019.1703354 · Cited by 72
Ji, M.-M., Wang, L., Zhan, Q., Xue, W., Zhao, Y., Zhao, X., Xu, P., Shen, Y., Liu, H., Janin, A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082024 · Cited by 71
MTOR-independent induction of autophagy in trabecular meshwork cells subjected to biaxial stretch
Porter, K. M., Jeyabalan, N., & Liton, P. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.02.010 · Cited by 70
Ying, H., Shen, X., Park, B., & Yue, B. Y. J. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009168 · Cited by 69
Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin
Swarup, G., & Sayyad, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01287 · Cited by 69
Belforte, N., Agostinone, J., Alarcon-Martinez, L., Villafranca-Baughman, D., Dotigny, F., Cueva Vargas, J. L., & Di Polo, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00466-z · Cited by 67 · cited 6×
“While not a direct comparison, the analysis of whole retina has been performed for western blots in previous studies to examine RGCs [24, 49, 58], and the detection of significant differences despite other retinal cell types present in samples underscores the likely robustness of these phenotypes…”
BackgroundResultInfluentialSelf-citationChalasani, M. L. S., Kumari, A., Radha, V., & Swarup, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095758 · Cited by 64
A role for polyamines in retinal ganglion cell excitotoxic death
Pernet, V., Bourgeois, P., & Polo, A. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04843.x · Cited by 61
Teotia, P., Van Hook, M. J., Wichman, C. S., Allingham, R. R., Hauser, M. A., & Ahmad, I. (2017) · Stem Cells · doi:10.1002/stem.2675 · Cited by 61
Differentiation of retinal organoids from human pluripotent stem cells
Fligor, C. M., Huang, K.-C., Lavekar, S. S., VanderWall, K. B., & Meyer, J. S. (2020) · Methods in cell biology · doi:10.1016/bs.mcb.2020.02.005 · Cited by 61
Self-citationVisual impairment in an optineurin mouse model of primary open-angle glaucoma
Tseng, H. C., Riday, T. T., McKee, C., Braine, C. E., Bomze, H., Barak, I., Marean-Reardon, C., John, S. W. M., Philpot, B. D., & Ehlers, M. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.012 · Cited by 60
Proietti Onori, M., Koene, L. M. C., Schäfer, C. B., Nellist, M., de Brito van Velze, M., Gao, Z., Elgersma, Y., & van Woerden, G. M. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001279 · Cited by 59
Defects in autophagy caused by glaucoma-associated mutations in optineurin
Sirohi, K., & Swarup, G. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.020 · Cited by 50
Zhang, S., Shao, Z., Liu, X., Hou, M., Cheng, F., Lei, D., & Yuan, H. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00432-0 · Cited by 50
Hirt, J., Porter, K., Dixon, A., McKinnon, S., & Liton, P. B. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0077-y · Cited by 49
Teotia, P., Van Hook, M. J., Fischer, D., & Ahmad, I. (2019) · Development · doi:10.1242/dev.178012 · Cited by 48
Optineurin in Huntington's disease intranuclear inclusions
Schwab, C., Yu, S., McGeer, E. G., & McGeer, P. L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.070 · Cited by 47
Madrakhimov, S. B., Yang, J. Y., Kim, J. H., Han, J. W., & Park, T. K. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00698-4 · Cited by 44
Gomes, C., VanderWall, K. B., Pan, Y., Lu, X., Lavekar, S. S., Huang, K.-C., Fligor, C. M., Harkin, J., Zhang, C., Cummins, T. R., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.006 · Cited by 42
Self-citationWiring the Binocular Visual Pathways
Murcia‐Belmonte, V., & Erskine, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133282 · Cited by 37
Autophagy in the eye: from physiology to pathophysiology
Liton, P. B., Boesze‐Battaglia, K., Boulton, M. E., Boya, P., Ferguson, T. A., Ganley, I. G., Kauppinen, A., Laurie, G. W., Mizushima, N., Morishita, H., et al. (2023) · Autophagy Reports · doi:10.1080/27694127.2023.2178996 · Cited by 37
Mori, F., Tanji, K., Toyoshima, Y., Yoshida, M., Kakita, A., Takahashi, H., & Wakabayashi, K. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0956-x · Cited by 36
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Ito, Y. A., Belforte, N., Cueva Vargas, J. L., & Di Polo, A. (2016) · Journal of Visualized Experiments · doi:10.3791/53731 · Cited by 36
Self-citationAutophagy in the Aging and Experimental Ocular Hypertensive Mouse Model
Nettesheim, A., Dixon, A., Shim, M. S., Coyne, A., Walsh, M. M., & Liton, P. B. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.10.31 · Cited by 36
Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models
Gomes, C., Huang, K.-C., Harkin, J., Baker, A., Hughes, J. M., Pan, Y., Tutrow, K., VanderWall, K. B., Lavekar, S. S., Hernandez, M., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.07.002 · Cited by 33
Self-citationJung, S., Chung, Y., Lee, Y., Lee, Y., Cho, J. W., Shin, E.-J., Kim, H.-C., & Oh, Y. J. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0210-6 · Cited by 32
Lavekar, S. S., Harkin, J., Hernandez, M., Gomes, C., Patil, S., Huang, K.-C., Puntambekar, S. S., Lamb, B. T., & Meyer, J. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-40382-4 · Cited by 26
Self-citationBack to the origins: Human brain organoids to investigate neurodegeneration
Faravelli, I., Costamagna, G., Tamanini, S., & Corti, S. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146561 · Cited by 25 · cited 1×
“…from multiple neurodegenerative diseases suggests that early alterations during development contribute to the later manifestation of neurodegenerative pathogenesis [15, 16], supporting the use of hPSC-based RGC systems to study at least some mechanistic aspects of glaucomatous neurodegeneration.”
BackgroundMarkovinovic, A., Ljutic, T., Béland, L.-C., & Munitic, I. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.007 · Cited by 25
Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma
Liu, X., Wang, Q., Shao, Z., Zhang, S., Hou, M., Jiang, M., Du, M., Li, J., & Yuan, H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab099 · Cited by 25
Huang, K.-C., Gomes, C., & Meyer, J. S. (2023) · Handbook of Experimental Pharmacology · doi:10.1007/164_2023_642 · Cited by 8
Self-citationAge-related effects of optineurin deficiency in the mouse eye
Su, C.-C., Liu, C., Adi, V., Chan, K. C., & Tseng, H. C. (2024) · Vision Research · doi:10.1016/j.visres.2024.108463 · Cited by 4
Predicting the genetic risk of glaucoma
Qassim, A., & Siggs, O. M. (2020) · The Biochemist · doi:10.1042/bio20200063 · Cited by 3
Cited by
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Zhang, Q., Xiang, S., Chen, X., Rong, Y., Huang, L., Chen, Z., Yao, K., Chen, W., Deng, C., & Wang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112545 · Cited by 28
Myeloid lineage C3 induces reactive gliosis and neuronal stress during CNS inflammation
Garton, T. P., Smith, M. D., Kesharwani, A., Gharagozloo, M., Oh, S., Na, C. H., Absinta, M., Reich, D. S., Zack, D. J., & Calabresi, P. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58708-3 · Cited by 18
Hao, H., Yu, B., Liu, X., Zhang, Y., & Xing, X.-L. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.04.04 · Cited by 7
Gomes, C., Huang, K.-C., Lavekar, S. S., Harkin, J., Prosser, C. G., Fang, Y., Kalem, C., Oblak, A. L., Zhang, C., & Meyer, J. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423682122 · Cited by 3
Self-citation
Metadata
- Authors
- Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., Di Polo, A., & Meyer, J. S.
- Affiliations
- Indiana University School of Medicine (US)
- Indiana University Indianapolis (US)
- Université de Montréal (CA)
- Corresponding author
- Meyer, Jason S.
- ORCID
- Venue
- Acta Neuropathologica Communications
- Published
- 2024-10-18
- Volume
- 12
- Issue
- 1
- Pages
- 164-164
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC11487784
- OpenAlex
- W4403513715
- Semantic Scholar
- 6d28e5c0a5de677d3a970287e3d24cbb9f71b576
- Cited by
- 19
- References
- 109
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 3
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- PubMed (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by-nc-nd)
- Funders
- National Eye Institute (R01EY033022, U24EY033269, R01EY030838)
- BrightFocus Foundation (G2020369, G2022003F)
- Glaucoma Research Foundation
- Indiana State Department of Health (26343)
- Fonds de Recherche du Québec - Santé (276181)
- Canadian Institutes of Health Research (458569)
- Gilbert Family Foundation (923016)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- optineurin, retinal ganglion cells, human pluripotent stem cells, glaucoma, neurodegeneration, autophagy, mTORC1 signaling, AMPK, ocular hypertension, neurite outgrowth, protein accumulation
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Autophagy, Humans, Retinal Ganglion Cells, Signal Transduction, Cell Cycle Proteins, Membrane Transport Proteins, Pluripotent Stem Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.